Objectives
The Nanoparticles Unit provides accredited tests and analyses for R&D on nanoparticles for therapeutic strategies.
Areas of impact and applications in the field
Theranostic nanoparticles hold the potential to revolutionize future disease management. Over the past ten years, there has been a growing interest in the engineering of various kinds of theranostic nanoparticles for simultaneous cancer imaging and therapy in small animals. Efficient targeting of theranostic nanoparticles to the tumor site is crucial for both diagnostic and therapeutic purposes. However, there are still difficulties in developing biocompatible theranostic nanoparticles with highly specific in vivo tumor targeting capabilities.
Services
- Accredited Sevices (Process is ongoing)
- Qualitative Structural Analysis of Plastic Materials (FTIR Method)
- Zeta Potential / Electrophoretic Mobility
- Particle Size Distribution / Hydrodynamic Diameter
